Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic pancreatitis: evolving paradigms.

Rupjyoti Talukdar1, Nripen Saikia, Dinesh Kumar Singal

  • 1Department of Gastroenterology, Pushpawati Singhania Research Institute, New Delhi, India.

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|July 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Real-world use of pancreatic enzyme replacement therapy: impact on patient-reported outcomes after acute pancreatitis.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same author

Heart Rate Variability as a Tell-tale Marker of Pain-related Autonomic Dysfunction in Chronic Pancreatitis.

Pancreas·2026
Same author

Urgent versus early ERCP in mild-to-moderate acute cholangitis: a randomised controlled trial.

Gut·2026
Same author

Static and dynamic quantitative sensory testing in chronic pancreatitis: Relation of pain sensitization to patient-reported outcomes and psychiatric comorbidities.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

The Jejunal Microbiota in Patients With Chronic Pancreatitis: Results From a Pilot Study.

Gastro hep advances·2026
Same author

High-end intestinal ultrasound versus mid-end systems benchmarked against tandem ileocolonoscopy in inflammatory bowel disease (HUMID): a paired prospective, validating confirmatory study.

EClinicalMedicine·2026
Same journal

Amylase and lipase in alcohol-induced acute pancreatitis: Time to rethink diagnostic thresholds?

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same journal

Progressive CA19-9 elevation with normal bilirubin as an escalation signal in pseudocyst-like pancreatic ductal adenocarcinoma.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same journal

EUS-guided coil and cyanoacrylate glue embolisation as a rescue for endovascular inaccessible splenic artery pseudoaneurysms in chronic pancreatitis.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same journal

Automated alert system and collaborative workflow improve treatment adherence and clinical outcomes in emergency care for acute pancreatitis: A quality improvement project.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same journal

Role of cathepsin B in spontaneous pancreatitis in T7D23A trypsinogen mutant mice.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
See all related articles

Chronic pancreatitis involves progressive fibrosis and pain, with pancreatic stellate cells (PSCs) key to its development. Research identifies molecular targets and potential therapies, including antioxidants and specific drugs, to slow disease progression in animal models.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Molecular Medicine

Background:

  • Chronic pancreatitis (CP) is a progressive disease causing fibrosis, pain, and functional loss.
  • Pancreatic stellate cells (PSCs) are central to CP pathogenesis and pancreatic fibrosis.
  • Understanding CP molecular mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate the molecular pathogenesis of chronic pancreatitis.
  • To identify novel molecular targets for therapeutic intervention in CP.
  • To review potential therapeutic agents for CP and fibrosis.

Main Methods:

  • Review of molecular mediators including growth factors (TGF-β, PDGF), cytokines (IL-1, IL-6, TNF-α), COX-2, and apoptosis proteins.
  • Elucidation of signaling pathways such as MAPK, PI3K, Ras, Raf-1, and PPAR-γ.

Related Experiment Videos

  • Evaluation of therapeutic agents in experimental CP and fibrosis models.

    • Main Results:

    • Key molecular mediators and pathways driving CP pathogenesis have been identified.
    • Novel molecular targets for CP treatment have emerged from pathobiological insights.
    • Several agents, including antioxidants, Saiko-keisi-to, troglitazone, Camostat mesilate, and Lovastatin, show promise in preclinical models.

    Conclusions:

    • Advances in understanding PSCs and molecular pathways have improved CP pathogenesis insights.
    • Targeting specific molecular mediators and pathways offers potential for novel CP therapies.
    • Preclinical studies indicate that various agents can retard the progression of experimental CP and fibrosis.